The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples